Platelet-to-lymphocyte ratio is associated with prognosis in patients with coronavirus disease-19. Lymphocyte to monocyte ratio as a screening tool for influenza. Merekoulias G, Alexopoulos EC, Belezos T, Panagiotopoulou E, Jelastopulu DM.Value of neutrophil to lymphocyte and platelet to lymphocyte ratios in pneumonia. The diagnostic and predictive role of NLR, d-NLR and PLR in COVID-19 patients. The SOFA score-development, utility and challenges of accurate assessment in clinical trials. Lambden S, Laterre PF, Levy MM, Francois B.Predictive value of SAPS II and APACHE II scoring systems for patient outcome in a medical intensive care unit. Calculated decisions: COVID-19 calculators during extreme resource-limited situations. Steinberg E, Balakrishna A, Habboushe J, Shawl A, Lee J.Clinical features predicting mortality risk in patients with viral pneumonia: The MuLBSTA score. Risk factors associated with acute respiratory distress syndrome and death in patients with coronavirus disease 2019 pneumonia in Wuhan, China [published correction appears in JAMA Intern Med 2020 180: 934-43. The WHO estimates of excess mortality associated with the COVID-19 pandemic.
Msemburi W, Karlinsky A, Knutson V, Aleshin-Guendel S, Chatterji S, Wakefield J.The COVID-19 cytokine storm what we know so far. Ragab D, Salah Eldin H, Taeimah M, Khattab R, Salem R.Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study.
Available from: (2005)-emergency-committee-regarding-the-outbreak-of-novel-coronavirus-(2019-ncov) Statement on the first meeting of the International Health Regulations (2005) Emergency Committee regarding the outbreak of novel coronavirus (2019-nCoV). Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia. The Coronavirus disease 2019 (COVID-19) pandemic. Conclusion: The combined use of the MuLSBTA score, SOFA score, and NLR after ICU admission for COVID-19 pneumonia will be more effective in predicting mortality. The survival time of patients with a high-risk MuLBTSA score was 12☐.78 days, while the survival time of patients with a low MuLBTSA score was 22.8☑.3 days. Patients were divided into two groups as high-risk and low-risk, considering a cut-off value of 12 for the MuLBTSA score. The MuLBSTA score was positively correlated with the neutrophil-to-lymphocyte ratio (NLR) and platelet-to-lymphocyte ratio (PLR), while it was negatively correlated with the lymphocyte-to-monocyte ratio (LMR). The AUC value was 0.863 for the SOFA score and 0.843 for the MuLBSTA score. Results: Of the 312 patients included in the study, 58.7% (n=183) were male and 41.3% (n=129) were female. Demographic data and laboratory results of patients were retrospectively reviewed. SOFA, MuLBSTA and APACHE-II scores of patients were estimated at ICU admission. Material and Method: This study included 312 patients admitted to ICU for COVID-19 infection. This study aimed to compare the effectiveness of the MuLBSTA (Multilobular infiltration, hypo-Lymphocytosis, Bacterial coinfection, Smoking history, hyper-Tension and Age) score with blood parameters, SOFA (Sequential Organ Failure Assessment), and APACHE II (Acute Physiology and Chronic Health Evaluation II) scores, and to investigate its significance in predicting 28-day mortality in patients diagnosed with COVID-19 and followed up in the intensive care unit (ICU). Tools are needed for effective diagnosis and better prediction of prognosis in the course of this disease. Aim: COVID-19 (coronavirus disease 2019) pneumonia is a serious condition with high mortality and morbidity.
0 kommentar(er)
